Mission BioCapital brings together two U.S.-based life-science venture firms: BioInnovation Capital and Mission Bay Capital
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Investors 1
Date | Name | Website |
14.06.2024 | Ono Ventur... | onoventure... |
Mentions in press and media 10
Date | Title | Description |
05.11.2024 | Houston's Innovation Landscape: Navigating Challenges and Embracing Opportunities | Houston is a city of dreams and determination. It’s a melting pot of innovation, where entrepreneurs are forging paths in uncharted territories. The recent Houston Innovation Awards highlighted this spirit, showcasing the wisdom of finalist... |
04.11.2024 | Overheard: 2024 Houston Innovation Awards finalists share top advice for fellow founders | There's a great deal of advice swirling around the world today about how to find success business. Why not take it from mentors and founders with a proven track record, like the finalists for this year's Houston Innovation Awards? From how ... |
24.10.2024 | Houston's Innovation Surge: Biotech Breakthroughs and Mars Simulations | Houston is a city where innovation thrives. It’s a melting pot of ideas, where science meets ambition. Recently, two stories have emerged that highlight this vibrant ecosystem: a groundbreaking biotech company and a NASA Mars simulation mis... |
23.10.2024 | Clinical-stage Houston cell therapy company closes $28.4M oversubscribed series A | An emerging biotech company in Houston has closed its series A with outsized success. March Biosciences' oversubscribed raise brought in $28.4 million of financing with Mission BioCapital and 4BIO Capital leading the pack of investors. The ... |
23.10.2024 | NASA taps 4 participants for Mars habitat simulation mission in Houston | Four individuals have been selected to go to Mars. Well, sort of. Obaid Alsuwaidi, Kristen Magas, Tiffany Snyder, and Anderson Wilder were picked by NASA to live for 45 days in a 650-square-foot Mars simulation located at Johnson Space Cent... |
18.09.2024 | Immunos Therapeutics raises USD11 million | ImmunOs’ lead program IOS-1002 is currently tested in a Phase Ia dose escalation clinical trial as a monotherapy and in combination with MSD’s anti-PD-1 therapy KEYTRUDA (pembrolizumab). IOS-1002 is a novel, multifunctional immunotherapy a... |
07.06.2022 | ImmunOs Therapeutics raises $74 Million to fund clinical trials | |
04.11.2021 | Google Cloud goes deep into financial services with $1 billion CME deal | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. I didn’t see this coming. Paid Content Why empathic leadership is critical to business success Fr... |
17.04.2012 | Southeastern IT, life science VC firm raising $125M new fund | Like many other VC firms, Harbert says it looks for seasoned entrepreneurs building early growth stage companies in large and growing markets. Areas of focus in healthcare include medical devices, healthcare IT, healthcare services and diag... |
- | Southeastern IT, life science VC firm raising $125M new fund | Good news for life science startups in Florida, Georgia, Virginia and other emerging hubs in the southeast U.S.: A large VC focusing its investments on information technology and healthcare is raising a new $125 million fund. Harbert Ventur... |